
Published On: Oct 2020
Published On: Oct 2020
KneeSegment Held Largest Share of Cartilage Degeneration Market in 2019
According to our new market research study on “South & Central AmericaCartilage Degeneration Marketto 2027 – Regional Analysis and Forecast – by Procedure Type, Applicationand EndUser”the market is expected to reach US$1,195.57 millionby 2027 from US$ 959.32 million in 2019; it is estimated to grow at a CAGR of 2.9% from 2020 to 2027. The report provides trends prevailing in the South & Central Americacartilage degenerationmarket and the factors driving the market growth along with those hindering it.
In 2019, the knee segment accounted for the highest share of the market. Growth of this segment is attributed to the increasing prevalence of knee injuries. Furthermore, increasing awareness of benefits provided by cartilage repair is also anticipated to drive the growth of knee segment.
The growth of the South & Central Americacartilage degeneration marketis mainly attributed togrowing number of sports injuries, and increasing prevalence of obesity. However, high cost of cartilage repair therapies is expected to restrict the market growth during the forecast period.
B. Braun Melsungen AG;Smith & Nephew;Stryker Corporation,CartiHeal, Inc.;and Vericel Corporation are among the leading companies operating in the South & Central Americacartilage degenerationmarket.
The Report Segments South & Central AmericaCartilage DegenerationMarketas Follows:
South & Central AmericaCartilage DegenerationMarket– By ProcedureType
South & Central AmericaCartilage Degeneration Market – By Application
South & Central AmericaCartilage DegenerationMarket – ByEndUser
South & Central AmericaCartilage DegenerationMarket– By Country